Phytochemical Profiling, Characterisation, and Antibacterial Potential of Syzygium aromaticum (Clove) Extracts Against Multidrug-Resistant Bacterial Strains
- 1IEC School of Pharmacy, IEC University, Kalu Jhanda, Baddi, Solan, Himachal Pradesh – 173205, India
Abstract
Syzygium aromaticum (clove) is well recognised for its diverse biological activities, including antimicrobial, antioxidant, and anti-inflammatory properties. The present study aimed to evaluate the antibacterial activity of clove bud extracts prepared by maceration with solvents of varying polarity n-hexane (non-polar), acetone (semi-polar), and ethanol (polar) against clinically relevant multidrug-resistant (MDR) bacterial strains. An initial qualitative phytochemical screening confirmed the presence of alkaloids, flavonoids, tannins, phenolic compounds, and terpenoids in the extracts. Antibacterial activity was determined by agar well diffusion against four organisms: Staphylococcus aureus (Gram-positive), Bacillus subtilis (Gram-positive), Escherichia coli (Gram-negative), and Pseudomonas aeruginosa (Gram-negative, MDR). The n-hexane extract exhibited the highest zone of inhibition for all organisms tested (up to 18 mm against S. aureus), followed by the acetone and ethanol extracts, indicating that the principal antibacterial constituents of clove are lipophilic in nature. GC-MS analysis of the most active n-hexane extract identified five major terpenoid constituents: β-caryophyllene (32.5%), α-humulene (12.3%), caryophyllene oxide (7.8%), α-copaene (5.6%), and δ-cadinene (4.2%). These terpenoids are known to disrupt bacterial cell membranes and inhibit microbial growth synergistically. Together, the results demonstrate that lipophilic clove extracts particularly the n-hexane fraction possess significant antibacterial activity against MDR organisms and represent a promising natural source for the development of alternative antimicrobial agents.
Related
- Phytochemical profiling-guided green synthesis and characterisation of silver nanoparticles using Catunaregam spinosa for biological applications
- Determinants of Antibacterial Activity in Humulus lupulus Hop Extracts: Phytochemical Profiling of Prenylated Acylphloroglucinols and Efficacy Against Methicillin-Resistant Staphylococcus aureus and Multidrug-Resistant Uropathogenic Escherichia coli
- Phytochemical Profiling and Antioxidant Potential of Ultrasonic-Assisted Methanolic Extracts from Different Organs of Geranium glaberrimum
- Genome mining, antibacterial activity, and metabolomic profiling reveal the biosynthetic potential of Burkholderia glumae isolates from Thailand with activity against clinically important bacterial pathogens
- Anti‐Helicobacter pylori Activity of Musa ‘False Horn’ (Musaceae), Syzygium aromaticum (Myrtaceae), Psidium guajava (Myrtaceae), Mangifera indica (Anacardiaceae), and Cymbopogon citratus (Poaceae) and Their Potential to Prevent and Eradicate H. pylori Biofilms
BibTeX
@article{kumar2026phytochemical,
title = {{Phytochemical Profiling, Characterisation, and Antibacterial Potential of Syzygium aromaticum (Clove) Extracts Against Multidrug-Resistant Bacterial Strains}},
author = {Amit Kumar and Jasveer Singh and Shiv Dutt and Navjot Singh Sethi and Jyoti Gupta},
journal = {International Journal of Research in Pharmaceutical Sciences},
year = {2026},
month = jun,
doi = {10.26452/ijrps.v17i2.4417},
url = {https://doi.org/10.26452/ijrps.v17i2.4417},
note = {CC BY},
}
RIS
TY - JOUR
TI - Phytochemical Profiling, Characterisation, and Antibacterial Potential of Syzygium aromaticum (Clove) Extracts Against Multidrug-Resistant Bacterial Strains
AU - Amit Kumar
AU - Jasveer Singh
AU - Shiv Dutt
AU - Navjot Singh Sethi
AU - Jyoti Gupta
PY - 2026
DA - 2026/06/01
JO - International Journal of Research in Pharmaceutical Sciences
DO - 10.26452/ijrps.v17i2.4417
UR - https://doi.org/10.26452/ijrps.v17i2.4417
AB - Syzygium aromaticum (clove) is well recognised for its diverse biological activities, including antimicrobial, antioxidant, and anti-inflammatory properties. The present study aimed to evaluate the antibacterial activity of clove bud extracts prepared by maceration with solvents of varying polarity n-hexane (non-polar), acetone (semi-polar), and ethanol (polar) against clinically relevant multidrug-resistant (MDR) bacterial strains. An initial qualitative phytochemical screening confirmed the presence of alkaloids, flavonoids, tannins, phenolic compounds, and terpenoids in the extracts. Antibacterial activity was determined by agar well diffusion against four organisms: Staphylococcus aureus (Gram-positive), Bacillus subtilis (Gram-positive), Escherichia coli (Gram-negative), and Pseudomonas aeruginosa (Gram-negative, MDR). The n-hexane extract exhibited the highest zone of inhibition for all organisms tested (up to 18 mm against S. aureus), followed by the acetone and ethanol extracts, indicating that the principal antibacterial constituents of clove are lipophilic in nature. GC-MS analysis of the most active n-hexane extract identified five major terpenoid constituents: β-caryophyllene (32.5%), α-humulene (12.3%), caryophyllene oxide (7.8%), α-copaene (5.6%), and δ-cadinene (4.2%). These terpenoids are known to disrupt bacterial cell membranes and inhibit microbial growth synergistically. Together, the results demonstrate that lipophilic clove extracts particularly the n-hexane fraction possess significant antibacterial activity against MDR organisms and represent a promising natural source for the development of alternative antimicrobial agents.
SN - 0975-7538
ER -